市场调查报告书
商品编码
1470940
伤口缝合和进阶创伤护理市场:按产品、应用和最终用户划分 - 2024-2030 年全球预测Wound Closure & Advanced Wound Care Market by Product (Collagen-Based Sealants, Fibrin-Based Sealants, Hydrocolloids-Based Sealants), Application (Acute Wounds, Chronic Wounds), End-User - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
伤口缝合和高级创伤护理市场规模预计到 2023 年为 163.4 亿美元,预计到 2024 年将达到 178.6 亿美元,到 2030 年将达到 307.8 亿美元,复合年增长率为 9.47%。
伤口缝合是一种医疗程序,旨在使伤口边缘接近,以促进癒合最大程度地降低感染风险。这个过程对于受伤或手术后恢復皮肤完整性和功能至关重要。伤口缝合技术根据伤口的性质和严重程度而有所不同,可能包括缝合、钉书钉、胶带或黏剂。此外,医疗保健投资的增加以及对缩短住院时间的关注也对市场成长做出了积极贡献。然而,与伤口护理和管理相关的高成本以及与慢性伤口护理相关的复杂问题可能会对市场成长带来挑战。然而,引入结合感测器和资料分析来监测创伤治疗和减少併发症的智慧创伤护理解决方案预计将为市场带来重大商机。此外,组织工程和干细胞治疗的进步为市场提供了重大机会。
主要市场统计 | |
---|---|
基准年[2023] | 163.4亿美元 |
预测年份 [2024] | 178.6亿美元 |
预测年份 [2030] | 307.8亿美元 |
复合年增长率(%) | 9.47% |
产品 支持组织癒合的胶原蛋白封闭剂的普及
胶原蛋白密封剂源自动物胶原蛋白,用于促进止血(止血)和支持组织癒合。它适用于各种手术和外伤伤口,以帮助凝固并作为新组织生长的支架。胶原蛋白密封剂因其天然的止血特性和优异的生物相容性而成为涉及重要器官的手术和易出血患者的首选。以纤维蛋白为基础的密封剂模仿体内凝血连锁的最后阶段,形成纤维蛋白凝块以止血。它们由浓缩的人类纤维蛋白原和凝血酶开发而成,可与机械闭合技术结合使用。以纤维蛋白为基础的密封剂有效地模仿人体的自然凝血过程并且完全可吸收,这就是为什么它们被用来治疗患有凝血障碍或接受复杂外科手术的患者。亲水胶体是吸收性黏性物质,当它们与伤口渗出物接触时形成凝胶。亲水胶体有助于维持湿润的伤口环境,有助于创伤治疗,也可用于压疮、烧伤和复杂伤口。这些密封剂可用于多种伤口类型,特别有利于处理轻度至中度渗出的伤口。合成黏剂是非生物化合物,可以快速黏合组织表面以闭合伤口。它们通常由氰基丙烯酸酯组成,是快速聚合剂,可提供即时的伤口缝合强度。合成黏剂通常用于闭合小割伤、撕裂伤和切口,主要是在需要快速、即时闭合伤口时。
应用 糖尿病足溃疡等慢性伤口的伤口缝合与进阶创伤护理偏好
慢性伤口,如腿部静脉性溃疡、褥疮和糖尿病足溃疡,是指在预期时间内无法癒合的伤口。这些伤口通常与糖尿病或循环系统疾病等潜在疾病有关,其持续性使得处理起来相当昂贵。治疗方法包括先进的敷料、伤口护理设备、生物合成和生物皮肤替代,旨在解决根本原因并促进癒合。糖尿病足溃疡(DFU)是糖尿病的主要併发症,对发病率和死亡率有重大影响。正确护理 DFU 对于预防可能导致截肢的感染疾病至关重要。压力性溃疡是由于皮肤长期受压而造成的皮肤和皮下组织损伤。压疮通常发生在卧床或行动不便的患者身上。压疮治疗包括专用床垫和垫子等减压装置,以及促进组织再生和防止感染的先进伤口敷料。腿部静脉性溃疡是由于血液循环不良,特别是静脉功能不全而引起的小腿慢性溃疡。治疗主要包括改善血液循环的压迫疗法和适合伤口环境的敷料。
最终用户:越来越多地被医院采用,从外科手术到急诊医学。
该诊所向门诊病人开放,治疗不需要住院的轻到中度伤口。诊所通常偏好经济高效、易于使用且患者周转速度快的产品。常用的产品有可吸收缝线、黏合带和局部皮肤黏剂等。此外,诊所可能会使用先进的敷料来加速癒合并减少后续观察的需要。在家庭医疗保健领域,需要易于患者和看护者独立使用的产品。优选能够保持湿润的伤口环境并且可以留在原处而不需要频繁更换的先进敷料。随着伤口护理设备变得更加方便和便携,居家照护的需求也不断增加。医院需要各种伤口缝合和护理产品来治疗各种伤口。首选产品可缩短患者復原时间,最大限度地降低感染风险,并可用于从手术到紧急护理的各种程序。常见的选择包括U形钉、高级缝线、手术密封剂以及用于烧烫伤治疗和手术伤口的高级敷料。
区域洞察
美洲的伤口缝合和先进创伤护理市场高度发达,拥有成熟的医疗基础设施来支持研究、开发和分销。美洲消费者的需求面向高品质、技术先进的产品,重点在于微创解决方案。美国拥有许多开创性的研究倡议,这些倡议通常得到公共和私营部门大规模投资的支持。市场也不断努力透过开发术后护理的替代疼痛管理解决方案来解决鸦片类药物危机。 EMEA(欧洲、中东和非洲)地区是一个多元化的市场,产品采用率和医疗保健支出水准各不相同。欧盟 (EU) 国家拥有标准化的法律规范,使其成为先进创伤护理产品的稳定市场。欧洲、中东和非洲地区的消费者需求差异很大,西欧更喜欢尖端产品,而非洲和中东则对价格更为敏感。欧洲、中东和非洲地区是尖端专利和研究的热点,并且经常受益于欧盟的资助和「地平线欧洲」等倡议。亚太地区伤口缝合和先进伤口护理市场正在经历显着成长。这是由人口老化、慢性伤口发病率上升以及医疗基础设施不断扩大所推动的。由于自付费用高昂的医疗费用,该地区消费者的需求受到对具有成本效益的产品的需求的推动。最近的投资主要集中在提高产品可用性和扩大本地製造能力。
FPNV定位矩阵
FPNV定位矩阵对于评估伤口缝合和进阶创伤护理市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对伤口缝合和高阶创伤护理市场供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.伤口缝合和高级创伤护理市场的市场规模和预测是多少?
2.在伤口缝合和高级创伤护理市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.伤口缝合和先进创伤护理市场的技术趋势和法规结构是什么?
4.伤口缝合和高级创伤护理市场主要供应商的市场占有率是多少?
5. 进入伤口缝合和先进创伤护理市场的适当型态和策略性手段是什么?
[192 Pages Report] The Wound Closure & Advanced Wound Care Market size was estimated at USD 16.34 billion in 2023 and expected to reach USD 17.86 billion in 2024, at a CAGR 9.47% to reach USD 30.78 billion by 2030.
Wound closure is a medical procedure aimed at approximating the edges of a wound to facilitate healing and minimize the risk of infection. This process is crucial for restoring the skin's integrity and function following an injury or surgery. Wound closure techniques vary depending on the nature and severity of the wound and include sutures, staples, adhesive tapes, and adhesives. Moreover, enhanced investment in healthcare and focus on reducing hospital stays contribute positively to market growth. However, the high costs associated with wound care and management and the complexity issues associated with chronic wound treatments may challenge the market growth. Nevertheless, the introduction of smart wound care solutions incorporating sensors and data analytics to monitor wound healing and reduce complications is expected to offer significant opportunities for the market. Moreover, advances in tissue engineering and stem cell therapy offer significant opportunities within the market.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 16.34 billion |
Estimated Year [2024] | USD 17.86 billion |
Forecast Year [2030] | USD 30.78 billion |
CAGR (%) | 9.47% |
Product: Proliferation of collagen-based sealants to support tissue healing
Collagen-based sealants are derived from animal collagen and are used to promote hemostasis (the cessation of bleeding) and to support tissue healing. They can be applied to various surgical and traumatic wounds to assist in clotting and act as a scaffold for new tissue growth. Collagen-based sealants are preferred in surgeries involving vital organs and patients prone to bleeding because of their natural hemostatic properties and excellent biocompatibility. Fibrin-based sealants mimic the final stages of the body's coagulation cascade, forming a fibrin clot to stop bleeding. They are developed from concentrated human fibrinogen and thrombin and can be used in conjunction with mechanical closure techniques. Fibrin-based sealants are used to treat patients with clotting disorders or undergoing complex surgical procedures, as they effectively mimic the body's natural clotting process and are fully resorbable. Hydrocolloids are absorbent, adhesive substances that form a gel when in contact with wound exudate. They help maintain a moist wound environment, which is beneficial for healing and can be used for pressure ulcers, burns, and complex wounds. These sealants are often preferred for their ability to be used on various wound types and are particularly beneficial in managing small to moderate exuding wounds. Synthetic adhesives are non-biological compounds that quickly bond tissue surfaces to close wounds. They often consist of cyanoacrylates, rapidly polymerizing agents providing immediate wound closure strength. Synthetic adhesives are commonly used to close minor cuts, lacerations, or incisions, mainly when speed and immediate sealing of the wound is required.
Application: Preferences for wound closure & advanced wound care in chronic wounds such as diabetic foot ulcers
Chronic wounds, such as venous leg ulcers, pressure ulcers, and diabetic foot ulcers, are wounds that fail to heal within the expected timeframe. These wounds are often associated with underlying health conditions, such as diabetes or circulatory problems, and can be considerably costly to manage due to their persistent nature. The treatment includes advanced dressings, negative pressure wound therapy devices, and biosynthetic and biological skin substitutes that aim to address the underlying causes and promote healing. Diabetic foot ulcers (DFUs) are a major complication of diabetes, with a significant impact on morbidity and mortality. Proper care of DFUs is critical in preventing infections that can lead to amputations. Pressure ulcers are injuries to the skin and underlying tissue resulting from prolonged pressure on the skin. They commonly occur in patients who are bedridden or immobile. Pressure ulcer treatment includes pressure-relieving devices such as specialized mattresses and cushions and advanced wound dressings that promote tissue regeneration and protect against infection. Venous leg ulcers are chronic sores that occur on the lower legs due to poor blood circulation, specifically venous insufficiency. The mainstay of treatment involves compression therapy to improve circulation, along with dressings that cater to the specific needs of the wound environment.
End-User: Increased adoption in hospital setting owing to procedures ranging from surgery to emergency care
Clinics cater to outpatients and handle minor to moderate wounds that do not require hospitalization. The preference in clinics is usually for cost-effective, easy-to-use products that allow for quick patient turnover. Products such as absorbable sutures, adhesive strips, and topical skin adhesives are commonly used. Additionally, clinics may utilize advanced dressings that promote faster healing and reduce the need for follow-up visits. The home healthcare segment requires products that are easy for patients or caregivers to use independently. Advanced dressings that maintain a moist wound environment and can be left in place without frequent changes are preferred. Negative pressure wound therapy devices are also seeing an increased demand for in-home care as technology becomes more accessible and portable. Hospitals require a broad spectrum of wound closure and care products to address the varied and often more complex wounds treated in this setting. The preferred products can reduce patient recovery time, minimize the risk of infection, and be used in procedures ranging from surgery to emergency care. Staples, advanced sutures, surgical sealants, and sophisticated dressings for burn care and surgical wounds are common choices.
Regional Insights
The wound closure and advanced wound care market in the Americas is highly developed, with well-established healthcare infrastructure supporting R&D and distribution. Consumer needs in the Americas are geared towards high-quality and technologically advanced products, focusing on minimally invasive solutions. The U.S. hosts several ground-breaking research initiatives, often backed by large investments from both private and public sectors. The market has also seen a wave of initiatives aiming to address the opioid crisis by developing alternative pain management solutions for post-surgical care. The EMEA region presents a diverse market with varying degrees of product adoption and healthcare spending. With their standardized regulatory framework, the European Union countries offer a stable market for advanced wound care products. Consumer needs across EMEA vary greatly, with Western Europe favoring cutting-edge products, while price sensitivity is more pronounced in Africa and the Middle East. The EMEA region is an active site for the latest patents and research, which often benefit from EU funding and initiatives such as Horizon Europe. The Asia Pacific region is witnessing significant growth in the wound closure and advanced wound care market. This can be attributed to an increasing aging population, a rising incidence of chronic wounds, and an expanding healthcare infrastructure. Consumer needs within the region are driven by a demand for cost-effective products due to high out-of-pocket healthcare spending. Recent investments are focused on improving product accessibility and expanding local production capabilities.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Wound Closure & Advanced Wound Care Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Wound Closure & Advanced Wound Care Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Wound Closure & Advanced Wound Care Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Argentum Medical, Axio Biosolutions Private Limited by Advamedica Inc., B. Braun SE, Cardinal Health, Inc., Coloplast A/S, Convatec Limited, Essity AB, Hollister Incorporated, Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Lohmann & Rauscher GmbH & Co. KG, Medline Industries, LP, Medtronic PLC, MIMEDX Group, Inc., Misonix, Inc. by Bioventus LLC, Molnlycke Health Care AB, Organogenesis Inc., Paul Hartmann AG, PolarityTE, Inc., Smith & Nephew PLC, Tides Medical, Tissue Regenix Ltd., Urgo Ltd., and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Wound Closure & Advanced Wound Care Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Wound Closure & Advanced Wound Care Market?
3. What are the technology trends and regulatory frameworks in the Wound Closure & Advanced Wound Care Market?
4. What is the market share of the leading vendors in the Wound Closure & Advanced Wound Care Market?
5. Which modes and strategic moves are suitable for entering the Wound Closure & Advanced Wound Care Market?